KINSHASA – The Congolese authorities have given the green light for the use of four experimental drugs against ebola. The latest outbreak of the deadly virus has so far claimed the lives of dozens of people in the African country, which is about sixty times as large as the Netherlands.
The authorities began earlier this month with the addition of the new means mAb114 to ten patients. They have since been a “positive evolution” is experienced, says the ministry of Health. The four other funds that are now also allowed to be used are developed by companies from different countries, including Israel, the US and Japan.
In the meantime, almost 1700 people were vaccinated with a means of the company Merck, which has been proven to be effective. The vaccine is administered to caregivers and people from the surroundings of patients. Ebola is contagious. During a previous outbreak in West Africa died more than 11,000 people.
WHO expects more ebola cases in Congo
Unsubscribe with 1 click